Genovera CJC-1295+ IPAMORELIN Genovera CJC-1295+ IPAMORELIN is a peptide combination that offers a unique approach to growth hormone therapy. The CJC-1295 is a synthetic analogue of growth-hormone-releasing hormone (GHRH), which binds to the GHRH receptor on the pituitary gland to stimulate GH secretion. Ipamorelin is a selective ghrelin receptor agonist that triggers GH release via the ghrelin pathway, without significantly elevating cortisol or prolactin levels. Together, they produce a synergistic GH pulse through complementary receptor pathways, mimicking the body's natural GH dynamics. This combination is particularly beneficial for those looking to support tissue regeneration, body fat metabolism, and hormone therapy.
